Pharmaceutical Technology

APRIL 26, 2023

In a 2020 study, Chan found devices that can easily calculate adherence to activation and inhalation could have the greatest utility in clinical practice. There is also huge potential to use these data to inform future drug development and clinical trials of new asthma medication,” adds Chan.

Medication Delivery 115

Medication Delivery Communication Drug Development 115

Express Pharma

SEPTEMBER 17, 2024

With an aim to become more value-driven, India’s pharma industry is looking beyond generics, targeting innovations in drug development. Students here lack the basic English communication skills and require direction on career options,” highlighting the need to improve skilling in institutes at the tier-2 and tier-3 levels.

Communication 105

Communication Drug Development 105

Pharmaceutical Technology

DECEMBER 9, 2022

Before the recent change in administration at the 2022 Presidential Election, Brazil’s health regulatory agency Anvisa had recently joined the Pharmaceutical Inspection Co-operation Scheme (PIC/S) in 2020, introducing new processes that would allow product owners to launch products in the national market with greater ease.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pulses

AUGUST 31, 2023

doi:10.1108/IJILT-06-2020-0108 Reiners D, Davahli MR, Karwowski W, Cruz-Neira C. Onime C, Uhomoibhi J, Wang H, Santachiara M. A reclassification of markers for mixed reality environments. Campus-wide information systems. 2021;38(1):161-173. The combination of Artificial Intelligence and Extended Reality: A Systematic Review. 2021;2:721933.

Medication Dispensing 78

Medication Dispensing Medication Labelling Packaging Labelling 78

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Diabetes Labelling Communication 105

Pharmaceutical Technology

MARCH 15, 2023

According to GlobalData’s Pharma Intelligence Center Deals Database, figure 1 shows the parent holding company SVB Financial Group and its subsidiaries were involved in more than $1.4bn in total venture financing raised from 2010 to 2022 for drug development. Free Report How is the Biopharmaceutical industry evolving?

Drug Development 59

Drug Development Communication 59

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Diabetes Labelling Communication 98

Pharmaceutical Technology

FEBRUARY 28, 2023

Orphan drug development is expanding Change is happening. 1983 was a pivotal year for the rare disease community, with the US Food and Drug Administration’s introduction of the Orphan Drug Act. With similar incentives offered by EU/EEA and UK law, orphan drug development has taken off.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development Communication 52

Putting Patients First Blog

JANUARY 30, 2024

The patient community defeated Congressional attempts to cut Medicaid funding and supported our constituents in the unwinding of COVID-19-era increased enrollment. We ended the year with 170 member organizations, up from 145 members in 2020. What’s more?

Communication 52

Communication Drug Development 52

Pharmaceutical Technology

JUNE 22, 2023

The European Commission’s (EC) plan to test a novel scheme to incentivise antimicrobial drug development companies remains beset by questions amidst the bloc’s drive to tackle the growing threat of antimicrobial resistance (AMR). However, additional initiatives that de-risk the development process are still needed, says Ruiz.

Drug Development 52

Drug Development Documentation Communication 52

Putting Patients First Blog

APRIL 7, 2025

14 In addition, sponsors should ensure that the datasets used to develop AI models reflect the intended patient population and disease variations. 15 ,16 Failure to do so risks overlooking meaningful variability and could reinforce historical limitations in drug development. Zaidan and I. Khair ElZarrad, Aaron Y.

Documentation 52

Documentation Communication Pharmaceutical Manufacturing Labelling 52

Putting Patients First Blog

APRIL 14, 2023

10: External Data Submission Timing The NHC understands the tight timeline for the drug selection and price negotiation processes. As discussed in the NHC’s 2020 white paper on the topic,3 patient value is multi-faceted, and any attempts to distill important dimensions of patient value and benefit into a single number is fraught.

Drug Pricing 40

Drug Pricing Drug Development Documentation Communication 40

pharmaphorum

MARCH 30, 2021

“There’s a lot that drug development for more common diseases could learn from rare disease R&D”. I think there’s a lot that drug development for more common diseases could learn from rare disease R&D.”. We have to be innovative to get around those challenges. Rare diseases during COVID.

Hospitals 111

Hospitals Communication Drug Development Pharmaceutical Companies 111

Putting Patients First Blog

APRIL 30, 2024

This method not only prioritizes the participant’s comprehension but also aligns with best practices in health communication that suggests a focused approach can significantly enhance understanding and retention of important information. The importance of using plain language in health communications is well-documented in literature.

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

pharmaphorum

OCTOBER 18, 2022

Listening to patients, patient advocacy groups, and others allows for better design of trial protocols, shaping tailored recruiting strategies, and helping to define what DCT solutions, including technologies, may most effectively and efficiently keep patients interested in, helping successful drug development to continue.

Drug Development 98

Drug Development Communication Vaccines 98

pharmaphorum

SEPTEMBER 27, 2021

The pharmaceutical industry is one of the most important industries in the world, providing lifesaving drugs and treatment to people who need it the most. trillion by end of 2020. In 2020, 53 novel medicines were approved by the FDA and of the patients who took part in trials, just 8% were black and 6% were Asian.

Vaccines 122

Vaccines Communication Drug Development 122

pharmaphorum

APRIL 11, 2022

Delivering value for patients doesn’t start and end in our R&D labs; actions can be implemented across all stages of the drug development lifecycle to encourage and embrace a pro-innovation environment. The role of innovation in value-based healthcare.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

pharmaphorum

SEPTEMBER 9, 2021

But when the pandemic struck in early 2020, we were found wanting. Public health agencies and pharma pivoted in countless ways, from decentralising clinical trials and accelerating research and development, to enabling remote care and remote working with rapid digitisation. This will, inevitably, take longer in some areas.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Putting Patients First Blog

FEBRUARY 6, 2024

Nature Communications, 11(6265). The price of progress: funding and financing Alzheimer’s disease drug development. Translational Medicine Communications, 4(18). Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research. [link] 2 Aiyegbusi, O., Macpherson, K., Washington, J.,

Communication 40

Communication Documentation Drug Development 40

pharmaphorum

OCTOBER 28, 2020

Data defines modern therapeutics, but this is almost uniquely confined to the clinical trial stages of drug development. PE isn’t traditional ‘communications’ where organisations talk to try and change patient behaviours, rather it’s about listening to patients to change corporate behaviours.

Vaccines 119

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 119

Pharmaceutical Technology

MARCH 24, 2023

Researchers expect TB to soon return to its pre-2020 position as the deadliest infectious disease globally. In light of World TB day on March 24, the field hopes to overcome some major barriers to the drug development landscape. million new cases reported worldwide. Please check your email to download the Report.

Vaccines 64

Vaccines Health and Personal Care Stores Immunization Immunity 64

FDA Law Blog: Biosimilars

JULY 9, 2024

FDA strongly encourages sponsors to discuss plans for a waiver early in the planning stages of the study or development program. If FDA determines that a waiver will be issued, it may consider public communications about the decision. Some unanswered questions remain.

Drug Development 59

Drug Development Communication Documentation Labelling 59

Putting Patients First Blog

SEPTEMBER 26, 2024

This includes being aware of historical injustices that may have contributed to mistrust in the medical system and understanding the unique needs and concerns of different communities. Effective communication with diverse populations is essential for ensuring that all individuals can participate in clinical trials.

Communication 52

Communication Clinical Pharmacology Documentation Drug Development 52

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. This was higher than the number of approvals in 2019 and 2020. Several drug development trends are driving injectables demand.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 27, 2023

LNPs are an adaptable, modular technology and when combined with microfluidic mixing, have the potential to accelerate development and commercialisation timelines and provide drug developers with an early foothold into a largely untapped market. Please check your email to download the Whitepaper.

Vaccines 52

Vaccines Drug Development Documentation Communication 52

pharmaphorum

APRIL 8, 2021

These previously-unknown antiviral properties of the drug surprised even its manufacturer, Eli Lilly, said Shields. “We We published our hypothesis in the Lancet on February 4 in 2020. But to defeat this virus and future pathogens, she said, we need to open communication channels between scientists in every country.

Drug Development 93

Drug Development Vaccines Documentation Communication 93

Pharmaceutical Technology

FEBRUARY 20, 2023

We are delighted to deepen our partnership with Teddy Lab that will enable us to build on existing knowledge and increase services within China to support customers with their global drug development programmes. Particularly, Teddy Lab Wuxi set up in 2020 with the great help of Wuxi Government. SZ) and Tigermed (300347.SZ

Research Laboratories 52

Research Laboratories Drug Development Vaccines Communication 52

Pharmaceutical Technology

FEBRUARY 20, 2023

On the other hand, a lack of diversity in clinical trial populations, particularly when the disease population is significantly underrepresented, greatly diminishes the quality of data obtained for drug safety and efficacy profiles. This may sound obvious, but it is still a major hurdle in drug development.

Vaccines 52

Vaccines Communication Immunization Immunity 52

Express Pharma

OCTOBER 31, 2024

In a recent interview, Suneela Thatte, VP and Head – Healthcare R&D for India, Merck KGaA Darmstadt discussed the evolution and strategic significance of the company’s Global Capability Center (GCC) in India, established in 2020. Merck too set up its GCC in India in 2020. It was a 15–20-member team when we started in 2020.

Drug Development 105

Drug Development Hospitals Process Improvement Documentation 105

FDA Law Blog: Biosimilars

OCTOBER 28, 2024

The Guidance provides a listing of domains for such assessment as pertains to general concerns ( e.g. , quality of life, physical health) and neurodevelopmental concerns ( e.g. , sensory, motor, cognition, communication). The Guidance is written carefully to communicate that these determinations are all very case-specific.

Clinical Pharmacology 64

Clinical Pharmacology Communication Drug Development 64